Your browser doesn't support javascript.
loading
In-Silico Drug Toxicity and Interaction Prediction for Plant Complexes Based on Virtual Screening and Text Mining.
Zhang, Feng; Ganesan, Kumar; Li, Yan; Chen, Jianping.
Afiliación
  • Zhang F; School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.
  • Ganesan K; Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen 518000, China.
  • Li Y; School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.
  • Chen J; Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen 518000, China.
Int J Mol Sci ; 23(17)2022 Sep 02.
Article en En | MEDLINE | ID: mdl-36077464
Potential drug toxicities and drug interactions of redundant compounds of plant complexes may cause unexpected clinical responses or even severe adverse events. On the other hand, super-additivity of drug interactions between natural products and synthetic drugs may be utilized to gain better performance in disease management. Although without enough datasets for prediction model training, based on the SwissSimilarity and PubChem platforms, for the first time, a feasible workflow of prediction of both toxicity and drug interaction of plant complexes was built in this study. The optimal similarity score threshold for toxicity prediction of this system is 0.6171, based on an analysis of 20 different herbal medicines. From the PubChem database, 31 different sections of toxicity information such as "Acute Effects", "NIOSH Toxicity Data", "Interactions", "Hepatotoxicity", "Carcinogenicity", "Symptoms", and "Human Toxicity Values" sections have been retrieved, with dozens of active compounds predicted to exert potential toxicities. In Spatholobus suberectus Dunn (SSD), there are 9 out of 24 active compounds predicted to play synergistic effects on cancer management with various drugs or factors. The synergism between SSD, luteolin and docetaxel in the management of triple-negative breast cancer was proved by the combination index assay, synergy score detection assay, and xenograft model.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas Asunto principal: Plantas Medicinales / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Neoplasias de la Mama Triple Negativas / Fabaceae Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas Asunto principal: Plantas Medicinales / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Neoplasias de la Mama Triple Negativas / Fabaceae Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: China